Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8 + cytotoxic T lymphocytes and CD4 + Th1 cells

By Moore A.   McGuirk P.   Adams S.   Jones W.C.   McGee J.P.   O'Hagan D.T.   Mills K.H.G.  

Vaccine, Vol. 13, Iss. 18, 1995-01 ,pp. : 1741-1749

Elsevier

Access to resources Recommend Favorite

Induction of cross-reactive cytotoxic T-lymphocyte responses specific for HIV-1 gp120 using saponin adjuvant (QS-21) supplemented subunit vaccine formulations

By Newman M.J.   Wu J.-Y.   Gardner B.H.   Anderson C.A.   Kensil C.R.   Recchia J.   Coughlin R.T.   Powell M.F.  

Vaccine, Vol. 15, Iss. 9, 1997-06 ,pp. : 1001-1007

Elsevier

Access to resources Recommend Favorite

Microparticles in MF59, a potent adjuvant combination for a recombinant protein vaccine against HIV-1

By O'Hagan D.T.   Ugozzoli M.   Barackman J.   Singh M.   Kazzaz J.   Higgins K.   Vancott T.C.   Ott G.  

Vaccine, Vol. 18, Iss. 17, 2000-03 ,pp. : 1793-1801

Elsevier

Access to resources Recommend Favorite

HIV-1 envelope protein gp120 triggers a Th2 response in mice that shifts to Th1 in the presence of human growth hormone

By Mellado M.   Llorente M.   Rodriguez-Frade J.M.   Lucas P.   Martinez-A C.   del Real G.  

Vaccine, Vol. 16, Iss. 11, 1998-07 ,pp. : 1111-1115

Elsevier

Access to resources Recommend Favorite

Combination of human cytomegalovirus recombinant immediate-early protein (IE1) with 80 nm cationic biovectors: protection from proteolysis and potentiation of presentation to CD4 + T-cell clones in vitro

By Prieur E.   Betbeder D.   Niedergang F.   Major M.   Alcover A.   Davignon J.-L.   Davrinche C.  

Vaccine, Vol. 14, Iss. 6, 1996-04 ,pp. : 511-520

Elsevier

Access to resources Recommend Favorite